We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+16.33%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.37B
AUM Growth
+$227M
(+11%)
Cap. Flow
-$5.81M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
19.78%
Holding
359
New
114
Increased
58
Reduced
128
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BellRing Brands
BRBR
|
+$32M |
| 2 |
QTS
QTS REALTY TRUST, INC.
QTS
|
+$18M |
| 3 |
PRFT
Perficient Inc
PRFT
|
+$15.7M |
| 4 |
Axos Financial
AX
|
+$14.4M |
| 5 |
Ameris Bancorp
ABCB
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$33M |
| 2 |
CADE
Cadence Bancorporation
CADE
|
+$29.6M |
| 3 |
VG
Vonage Holdings Corporation
VG
|
+$15.7M |
| 4 |
ARQL
Arqule Inc
ARQL
|
+$15.6M |
| 5 |
Karyopharm Therapeutics
KPTI
|
+$14.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.26% |
| 2 | Consumer Discretionary | 16.72% |
| 3 | Industrials | 15.68% |
| 4 | Technology | 14.21% |
| 5 | Consumer Staples | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
251
DELISTED
Select Medical
SEM
| $118K | 0.01% |
+9,345
| New | +$101K |
|
252
Peoples Financial Services
PFIS
$695M
| $115K | ﹤0.01% |
+2,293
| New | +$112K |
|
253
Walt Disney
DIS
$165B
| $108K | ﹤0.01% |
+750
| New | +$105K |
|
|
GNC
254
DELISTED
GNC Holdings, Inc.
GNC
| $108K | ﹤0.01% |
+39,890
| New | +$107K |
|
255
Kennametal
KMT
$2.68B
| $107K | ﹤0.01% |
+2,888
| New | +$96.7K |
|
256
Cannae Holdings
CNNE
$647M
| $98K | ﹤0.01% |
+2,644
| New | +$86.9K |
|
257
York Water
YORW
$505M
| $97K | ﹤0.01% |
+2,110
| New | +$92.5K |
|
258
Erie Indemnity
ERIE
$11.7B
| $95K | ﹤0.01% |
+570
| New | +$101K |
|
259
ICF International
ICFI
$1.44B
| $85K | ﹤0.01% |
+931
| New | +$80.1K |
|
260
OraSure Technologies
OSUR
$273M
| $76K | ﹤0.01% |
+9,460
| New | +$76.5K |
|
261
Gray Television
GTN
$407M
| $72K | ﹤0.01% |
+3,368
| New | +$62.5K |
|
262
Caesars Entertainment
CZR
$6.1B
| $70K | ﹤0.01% |
+1,176
| New | +$58.2K |
|
263
S&T Bancorp
STBA
$1.86B
| $67K | ﹤0.01% |
+1,670
| New | +$63.2K |
|
|
CUB
264
DELISTED
Cubic Corporation
CUB
| $61K | ﹤0.01% |
+954
| New | +$64.5K |
|
265
Flowers Foods
FLO
$1.64B
| $59K | ﹤0.01% |
+2,705
| New | +$58.8K |
|
266
Teleflex
TFX
$5.85B
| $56K | ﹤0.01% |
+150
| New | +$51.6K |
|
267
UFP Industries
UFPI
$4.97B
| $55K | ﹤0.01% |
+1,154
| New | +$54.4K |
|
|
SP
268
DELISTED
SP Plus Corporation
SP
| $52K | ﹤0.01% |
+1,217
| New | +$51.2K |
|
|
MTOR
269
DELISTED
MERITOR, Inc.
MTOR
| $52K | ﹤0.01% |
+1,999
| New | +$45.1K |
|
270
Photronics
PLAB
$1.79B
| $51K | ﹤0.01% |
+3,250
| New | +$40.9K |
|
271
Kulicke & Soffa
KLIC
$5.3B
| $49K | ﹤0.01% |
+1,796
| New | +$44.3K |
|
272
Cerence
CRNC
$382M
| $48K | ﹤0.01% |
+2,109
| New | +$34.6K |
|
273
Coherent
COHR
$55.2B
| $47K | ﹤0.01% |
+1,391
| New | +$44.3K |
|
274
GameStop
GME
$9.5B
| $47K | ﹤0.01% |
+30,860
| New | +$45.3K |
|
275
Federated Hermes
FHI
$4.4B
| $46K | ﹤0.01% |
+1,410
| New | +$46K |
|
Similar funds
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
FAM
Emerald Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, Emerald Advisers held 359 positions worth $2.37B, up 11% from $2.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Emerald Advisers's Q4 2019 filing shows 114 new, 58 increased, 128 reduced and 21 closed positions. Its largest new stake was BellRing Brands: 1,634,376 shares worth $34.8M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $33M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Emerald Advisers's largest Q4 2019 buy was BellRing Brands: 1,634,376 shares worth $34.8M.
- Emerald Advisers added most to Perficient Inc in Q4 2019, an estimated $15.7M increase.
- Emerald Advisers's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $33M.
- Emerald Advisers fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $13.2M.
- Emerald Advisers's ten largest holdings make up 20% of its $2.37B portfolio in Q4 2019.
- Emerald Advisers opened 114 new positions and closed 21 in Q4 2019.
- Emerald Advisers's portfolio value rose 11% quarter-over-quarter to $2.37B.
Based on Emerald Advisers's 13F filing for Q4 2019, filed 29 Jan 2020.